FTUS
ONC

Flow Traders U.S.’s BeOne Medicines Ltd ONC Stock Holding History

Flow Traders U.S.’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-906
Closed -$309K – 1334
2025
Q3 		$309K Buy
+906
New +$275K 0.01% 735
2022
Q1 		– Sell
-860
Closed -$233K – 1043
2021
Q4 		$233K Buy
+860
New +$290K 0.01% 681

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Flow Traders U.S.'s ONC Position: Q4 2025 in Review

Flow Traders U.S. sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 906 shares — an estimated $309K sold.

Flow Traders U.S. first reported a position in ONC in Q4 2021 and held it in 2 quarters. The position peaked at $309K in Q3 2025. 286 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Flow Traders U.S. reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Flow Traders U.S. sold 906 BeOne Medicines Ltd shares in Q4 2025, an estimated $309K.
  • Flow Traders U.S. first reported a position in BeOne Medicines Ltd in Q4 2021 and held it in 2 quarters.
  • Flow Traders U.S.'s BeOne Medicines Ltd position peaked at $309K in Q3 2025.
  • 286 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Flow Traders U.S.'s 13F filing for Q4 2025, filed 13 Feb 2026.